Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Opendoor Technologies Inc is a real estate services business based in the US. Opendoor Technologies shares (OPEN) are listed on the NASDAQ and all prices are listed in US Dollars. Opendoor Technologies employs 1,048 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$20.35|
|52-week range||$13.44 - $39.24|
|50-day moving average||$17.29|
|200-day moving average||$18.04|
|Wall St. target price||$31.20|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.64|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-17)||11.02%|
|1 month (2021-08-25)||17.77%|
|3 months (2021-06-25)||18.94%|
|6 months (2021-03-25)||-11.68%|
|1 year (2020-09-25)||23.93%|
|2 years (2019-09-21)||N/A|
|3 years (2018-09-21)||N/A|
|5 years (2016-09-21)||N/A|
|Revenue TTM||$2.5 billion|
|Gross profit TTM||$221.7 million|
|Return on assets TTM||-9.79%|
|Return on equity TTM||-39.38%|
|Market capitalisation||$12.3 billion|
TTM: trailing 12 months
There are currently 43.9 million Opendoor Technologies shares held short by investors – that's known as Opendoor Technologies's "short interest". This figure is 98.7% up from 22.1 million last month.
There are a few different ways that this level of interest in shorting Opendoor Technologies shares can be evaluated.
Opendoor Technologies's "short interest ratio" (SIR) is the quantity of Opendoor Technologies shares currently shorted divided by the average quantity of Opendoor Technologies shares traded daily (recently around 13.6 million). Opendoor Technologies's SIR currently stands at 3.24. In other words for every 100,000 Opendoor Technologies shares traded daily on the market, roughly 3240 shares are currently held short.
To gain some more context, you can compare Opendoor Technologies's short interest ratio against those of similar companies.
However Opendoor Technologies's short interest can also be evaluated against the total number of Opendoor Technologies shares, or, against the total number of tradable Opendoor Technologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Opendoor Technologies's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Opendoor Technologies shares in existence, roughly 70 shares are currently held short) or 0.1129% of the tradable shares (for every 100,000 tradable Opendoor Technologies shares, roughly 113 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Opendoor Technologies.
Find out more about how you can short Opendoor Technologies stock.
We're not expecting Opendoor Technologies to pay a dividend over the next 12 months.
Opendoor Technologies Inc. operates a digital platform for residential real estate in the United States. Its platform enables consumers to buy and sell a home online. The company was founded in 2014 and is headquartered in San Francisco, California. .
Everything we know about the Enfusion IPO, plus information on how to buy in.
Everything we know about the Intuity Medical IPO, plus information on how to buy in.
Everything we know about the Pyxis Oncology IPO, plus information on how to buy in.
Everything we know about the AEON Biopharma IPO, plus information on how to buy in.
Everything we know about the IHS Holding Ltd IPO, plus information on how to buy in.
Everything we know about the BT Brands IPO, plus information on how to buy in.
Everything we know about the Immix IPO, plus information on how to buy in.
Everything we know about the Keter Group SA IPO, plus information on how to buy in.
Everything we know about the Theseus Pharmaceuticals IPO, plus information on how to buy in.
Everything we know about the MiNK Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.